Diabetes weight management in clinical practice-the why WAIT model

US Endocrinology

Volumn 4, Issue 2, 2008, Pages 49-54

  Hamdy, Osama ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84893807400     PISSN: 17583918     EISSN: 17583926     Source Type: Journal    
DOI: 10.17925/use.2008.04.2.49     Document Type: Article

References (31)

1. King H, Aubert RE, Herman WH., Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections, Diabetes Care, 1998;21(9):1414-31.
2. Flegal KM, Carroll MD, Ogden CL, Johnson CL., Prevalence and trends in obesity among US adults, 1999-2000, JAMA, 2002;288:1723-7.
3. Lin SX, Pi-Sunyer EX., Prevalence of the metabolic syndrome among US middle-aged and older adults with and without diabetes-a preliminary analysis of the NHANES 1999-2002 data, Ethn Dis, 2007;17(1):35-9.
4. Turner RC, Cull CA, Frighi V, Holman RR., Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group, JAMA, 1999;281(21):2005-12.
5. Henry RR, Gumbiner B, Ditzler T, et al., Intensive conventional insulin therapy for type II diabetes. Metabolic effects during a 6-mo outpatient trial, Diabetes Care, 1993;16(1):21-31.
6. Hamdy O, Ledbury S, Mullooly C, et al., Lifestyle modification improves endothelial function in obese subjects with the insulin resistance syndrome, Diabetes Care, 2003;26(7):2119-25.
7. Monzillo LU, Hamdy O, Horton ES, et al., Effect of lifestyle modification on adipokine levels in obese subjects with insulin resistance, Obes Res Sep, 2003;11(9):1048-54.
8. Pi-Sunyer X, Blackburn G, Brancati FL, et al., Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial, Diabetes Care, 2007;30(6):1374-83.
9. Price JH, Desmond SM, Krol RA, et al., Family practice physicians' beliefs, attitudes, and practices regarding obesity, Am J Prev Med, 1987;3(6):339-45.
10. Hill JO, Wyatt H., Outpatient management of obesity: a primary care perspective, Obes Res, 2002;10(Suppl. 2):124S-130S.
11. Becker RH, Frick AD., Clinical pharmacokinetics and pharmacodynamics of insulin glulisine, Clin Pharmacokinet, 2008;47(1):7-20.
12. Dornhorst A, Lüddeke HJ, Sreenan S, et al., PREDICTIVE Study Group, Insulin detemir improves glycaemic control without weight gain in insulin-naïve patients with type 2 diabetes: subgroup analysis from the PREDICTIVE study, Int J Clin Pract, 2008;62(4):659-65
13. Rosenstock J, Davies M, Home PD, et al., A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes, Diabetologia, 2008;51(3):408-16.
14. Giusti J, Rizzotto JA., Interpreting the Joslin Diabetes Center and Joslin Clinic Clinical Nutrition Guideline for Overweight and Obese Adults With Type 2 Diabetes, Curr Diab Rep, 2006;6(5):405-8.
15. Campbell A., Tackling 'diabesity' head-on. Joslin Diabetes Center's new nutrition guideline, Diabetes Self Manag, 2005;22(6):40, 42-44.
16. Fenicchia LM, Kanaley JA, Azevedo JL Jr, et al., Influence of resistance exercise training on glucose control in women with type 2 diabetes, Metabolism, 2004;53(3):284-9.
17. Cuff DJ, Meneilly GS, Martin A, et al., Effective exercise modality to reduce insulin resistance in women with type 2 diabetes, Diabetes Care, 2003;26(11):2977-82.
18. Daly RM, Dunstan DW, Owen N, et al., Does high-intensity resistance training maintain bone mass during moderate weight loss in older overweight adults with type 2 diabetes?, Osteoporos Int, 2005;16(12):1703-12.
19. Knowler WC, Barrett-Connor E, Fowler SE, et al., Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin, N Engl J Med, 2002;346(6):393-403.
20. Wadden TA, Osei S., The treatment of obesity: An overview. In: Wadden TA, Stunkard AJ (eds), Handbook of Obesity Treatment, New York, New York: Guildford Press, 2002:229-48.
21. Hickman IJ, Jonsson JR, Prins JB, et al., Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life, Gut, 2004;53(3):413-19.
22. Dixon JB, Bhathal PS, O'Brien PE., Weight loss and non-alcoholic fatty liver disease: falls in gamma-glutamyl transferase concentrations are associated with histologic improvement, Obes Surg, 2006;16(10):1278-86.
23. Hsieh CJ,Wang PW., Effectiveness of weight loss in the elderly with type 2 diabetes mellitus, J Endocrinol Invest, 2005;28(11):973-7.
24. Parker B, Noakes M, Luscombe N, Clifton P., Effect of a highprotein, high-monounsaturated fat weight loss diet on glycemic control and lipid levels in type 2 diabetes, Diabetes Care, 2002;25(3):425-30.
25. Navarro-Diaz M, Serra A, Romero R, et al., Effect of drastic weight loss after bariatric surgery on renal parameters in extremely obese patients: long-term follow-up, J Am Soc Nephrol, 2006;17(12 Suppl. 3):S213-217.
26. Saiki A, Nagayama D, Ohhira M, et al., Effect of weight loss using formula diet on renal function in obese patients with diabetic nephropathy, Int J Obes (Lond), 2005;29(9):1115-20.
27. Skov AR, Toubro S, Bulow J, et al., Changes in renal function during weight loss induced by high vs low-protein low-fat diets in overweight subjects, Int J Obes Relat Metab Disord, 1999;23(11):1170-77.
28. Gannon MC, Nuttall FQ., Control of blood glucose in type 2 diabetes without weight loss by modification of diet composition, Nutr Metab (Lond), 2006;3:16.
29. Brinkworth GD, Noakes M, Parker B, et al., Long-term effects of advice to consume a high-protein, low-fat diet, rather than a conventional weight-loss diet, in obese adults with type 2 diabetes: one-year follow-up of a randomised trial, Diabetologia, 2004;47(10):1677-86.
30. Aucott L, Poobalan A, Smith WC, et al.,Weight loss in obese diabetic and non-diabetic individuals and long-term diabetes outcomes-a systematic review, Diabetes Obes Metab, 2004;6(2):85-94.
31. Yu AP,Wu EQ, Birnbaum HG, et al., Short-term economic impact of body weight change among patients with type 2 diabetes treated with antidiabetic agents: analysis using claims, laboratory, and medical record data, Curr Med Res Opin, 2007;23(9):2157-69.